| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1019599674 |
| P356 | DOI | 10.1186/1471-2288-12-111 |
| P932 | PMC publication ID | 3564789 |
| P698 | PubMed publication ID | 22846171 |
| P5875 | ResearchGate publication ID | 230587897 |
| P50 | author | David Moher | Q28036061 |
| Claire Bombardier | Q28322236 | ||
| Joseph Beyene | Q28322514 | ||
| P2093 | author name string | Joel J Gagnier | |
| Heather Boon | |||
| P2860 | cites work | Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement | Q21562278 |
| Measuring inconsistency in meta-analyses | Q27860655 | ||
| Meta-analysis in clinical trials | Q27860779 | ||
| How should meta-regression analyses be undertaken and interpreted? | Q28193388 | ||
| Exploring heterogeneity in meta-analysis: is the L'Abbé plot useful? | Q52206226 | ||
| Borrowing strength from external trials in a meta-analysis | Q52287071 | ||
| The population risk as an explanatory variable in research synthesis of clinical trials | Q52298897 | ||
| Inter-study differences: how should they influence the interpretation and analysis of results? | Q52599205 | ||
| Systematic reviews of trials and other studies. | Q52912655 | ||
| A note on variance estimation in random effects meta-regression | Q52980556 | ||
| Systematic reviews: time to address clinical and policy relevance as well as methodological rigor | Q54243022 | ||
| Avoidable waste in the production and reporting of research evidence | Q56028127 | ||
| Heterogeneity and meta-analyses: do study results truly differ? | Q57447581 | ||
| Systematic Reviews and Meta-Analysis | Q57970162 | ||
| Using mixed treatment comparisons and meta-regression to perform indirect comparisons to estimate the efficacy of biologic treatments in rheumatoid arthritis | Q57995927 | ||
| Multiple-outcome meta-analysis of clinical trials | Q71156715 | ||
| A random-effects regression model for meta-analysis | Q72228939 | ||
| A logistic model for trend in 2 x 2 x kappa tables with applications to meta-analyses | Q73331837 | ||
| Improved tests for a random effects meta-regression with a single covariate | Q73855792 | ||
| The way in which intervention studies have "personality" and why it is important to meta-analysis | Q74426136 | ||
| Multilevel models for meta-analysis, and their application to absolute risk differences | Q77408685 | ||
| An empirical study of the effect of the control rate as a predictor of treatment efficacy in meta-analysis of clinical trials | Q77429377 | ||
| Diagnostic statistical procedures in medical meta-analyses | Q78209664 | ||
| Assessing heterogeneity in meta-analyses of Helicobacter pylori infection-related clinical studies: a critical appraisal | Q81182073 | ||
| Analysing the relationship between treatment effect and underlying risk in meta-analysis: comparison and development of approaches | Q52070121 | ||
| Explaining heterogeneity in meta-analysis: a comparison of methods | Q52141807 | ||
| A consumer's guide to subgroup analyses | Q41111858 | ||
| Variation in baseline risk as an explanation of heterogeneity in meta-analysis | Q41713253 | ||
| An empirical study using permutation-based resampling in meta-regression | Q42073360 | ||
| Two cheers for meta-analysis: problems and opportunities in aggregating results of clinical trials | Q42593071 | ||
| Meta-regression with partial information on summary trial or patient characteristics | Q43189057 | ||
| Investigating underlying risk as a source of heterogeneity in meta-analysis | Q43454034 | ||
| Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates | Q43796813 | ||
| Bayesian random effects meta-analysis of trials with binary outcomes: methods for the absolute risk difference and relative risk scales | Q44059947 | ||
| Importance of events per independent variable in proportional hazards analysis. I. Background, goals, and general strategy | Q44234976 | ||
| Heterogeneity can impair the results of Cochrane meta-analyses despite accordance with statistical guidelines | Q45799044 | ||
| Meta-analysis: recent developments in quantitative methods for literature reviews. | Q45939380 | ||
| Semi-parametric modelling of the distribution of the baseline risk in meta-analysis | Q51905262 | ||
| Evaluation of underlying risk as a source of heterogeneity in meta-analyses: a simulation study of Bayesian and frequentist implementations of three models | Q51915747 | ||
| Meta-regression detected associations between heterogeneous treatment effects and study-level, but not patient-level, factors | Q51990048 | ||
| A graphical method for exploring heterogeneity in meta-analyses: application to a meta-analysis of 65 trials | Q52032770 | ||
| Baseline risk as predictor of treatment benefit: three clinical meta-re-analyses | Q52069974 | ||
| Systematic reviews of adverse effects: framework for a structured approach | Q28218100 | ||
| An international registry of systematic-review protocols | Q28736157 | ||
| Bench-to-bedside review: avoiding pitfalls in critical care meta-analysis--funnel plots, risk estimates, types of heterogeneity, baseline risk and the ecologic fallacy | Q28756698 | ||
| Quantitative Synthesis in Systematic Reviews | Q29614894 | ||
| 2009 updated method guidelines for systematic reviews in the Cochrane Back Review Group | Q29619952 | ||
| Updated method guidelines for systematic reviews in the cochrane collaboration back review group | Q29620807 | ||
| Predictive modeling and heterogeneity of baseline risk in meta-analysis of individual patient data | Q30635282 | ||
| Meta-analysis of binary data: which within study variance estimate to use? | Q30655197 | ||
| Meta-analysis of continuous outcome data from individual patients. | Q30657054 | ||
| A comparison of summary patient-level covariates in meta-regression with individual patient data meta-analysis | Q30669346 | ||
| Individual patient- versus group-level data meta-regressions for the investigation of treatment effect modifiers: ecological bias rears its ugly head | Q30670986 | ||
| Avoidable waste in the production and reporting of research evidence | Q30911439 | ||
| Flexible meta-regression functions for modeling aggregate dose-response data, with an application to alcohol and mortality | Q30932972 | ||
| Investigating heterogeneity in an individual patient data meta-analysis of time to event outcomes | Q30981851 | ||
| Random effects survival models gave a better understanding of heterogeneity in individual patient data meta-analyses. | Q30983032 | ||
| An overview of methods and empirical comparison of aggregate data and individual patient data results for investigating heterogeneity in meta-analysis of time-to-event outcomes | Q31004727 | ||
| Meta-analysis of individual patient data from randomized trials: a review of methods used in practice. | Q31016826 | ||
| Covariate heterogeneity in meta-analysis: criteria for deciding between meta-regression and individual patient data | Q31088951 | ||
| A systematic review of analytical methods used to study subgroups in (individual patient data) meta-analyses | Q31130344 | ||
| CoPlot: a tool for visualizing multivariate data in medicine | Q31134871 | ||
| Meta-analysis of continuous outcomes combining individual patient data and aggregate data | Q31139467 | ||
| Assessing treatment-time interaction in clinical trials with time to event data: a meta-analysis of hypertension trials | Q31919300 | ||
| Guides for reading and interpreting systematic reviews: III. How did the authors synthesize the data and make their conclusions? | Q32019717 | ||
| Knowledge for knowledge translation: the role of the Cochrane Collaboration | Q33237434 | ||
| Clinical heterogeneity was a common problem in Cochrane reviews of physiotherapy and occupational therapy | Q33253271 | ||
| Impact of allocation concealment on conclusions drawn from meta-analyses of randomized trials | Q33285346 | ||
| Meta-analysis of individual patient data versus aggregate data from longitudinal clinical trials | Q33414055 | ||
| Interpreting and evaluating meta-analysis | Q33567774 | ||
| Subgroup effects despite homogeneous heterogeneity test results | Q33579521 | ||
| Meta-analysis: when and how. | Q33673474 | ||
| Deriving treatment recommendations from evidence within randomized trials. The role and limitation of meta-analysis | Q33744011 | ||
| Principles of metaanalysis | Q33824889 | ||
| Mediation analyses: applications in nutrition research and reading the literature | Q33830781 | ||
| Bayesian methods in health technology assessment: a review | Q34116699 | ||
| Resolving conflicting clinical trials: Guidelines for meta-analysis | Q34176336 | ||
| Invited review: Integrating quantitative findings from multiple studies using mixed model methodology | Q34250572 | ||
| Systematic reviews in health care: Investigating and dealing with publication and other biases in meta-analysis | Q34307827 | ||
| A simulation study of the number of events per variable in logistic regression analysis | Q34411363 | ||
| Statistical heterogeneity in systematic reviews of clinical trials: a critical appraisal of guidelines and practice. | Q34513646 | ||
| Advanced methods in meta-analysis: multivariate approach and meta-regression. | Q34523076 | ||
| Investigating causes of heterogeneity in systematic reviews | Q34733063 | ||
| Controlling the risk of spurious findings from meta-regression. | Q35782230 | ||
| Treating individuals 4: can meta-analysis help target interventions at individuals most likely to benefit? | Q36017145 | ||
| Tips for learners of evidence-based medicine: 4. Assessing heterogeneity of primary studies in systematic reviews and whether to combine their results | Q36058222 | ||
| Meta-analysis. Beyond the grand mean? | Q36247607 | ||
| Summaries of findings, descriptions of interventions, and information about adverse effects would make reviews more informative | Q36530798 | ||
| Systematic reviews and knowledge translation | Q36569405 | ||
| Method guidelines for Cochrane Musculoskeletal Group systematic reviews. | Q36645821 | ||
| Invited commentary: benefits of heterogeneity in meta-analysis of data from epidemiologic studies | Q36688710 | ||
| Recent developments in meta-analysis. | Q36859537 | ||
| Why sources of heterogeneity in meta-analysis should be investigated | Q36888653 | ||
| Creating clinically relevant knowledge from systematic reviews: the challenges of knowledge translation | Q36903874 | ||
| Exploring heterogeneity in meta-analyses: needs, resources and challenges | Q37072917 | ||
| An overview of statistical issues and methods of meta-analysis | Q37151034 | ||
| What is missing from descriptions of treatment in trials and reviews? | Q37201306 | ||
| Attention should be given to multiplicity issues in systematic reviews | Q37237919 | ||
| Interpretation of tests of heterogeneity and bias in meta-analysis | Q37329334 | ||
| A case study of multiple-treatments meta-analysis demonstrates that covariates should be considered | Q37373846 | ||
| Understanding heterogeneity in meta-analysis: the role of meta-regression | Q37600940 | ||
| Group-based trajectory modeling in clinical research | Q37700698 | ||
| Intervention effects in the case of heterogeneity between three subgroups. Assessment within the framework of systematic reviews | Q37774274 | ||
| Taking healthcare interventions from trial to practice | Q37780029 | ||
| Use of hierarchical models for meta-analysis: experience in the metabolic ward studies of diet and blood cholesterol | Q39012974 | ||
| A model for integrating fixed-, random-, and mixed-effects meta-analyses into structural equation modeling | Q40049870 | ||
| Exploratory or analytic meta-analysis: should we distinguish between them? | Q40590952 | ||
| Methodologic guidelines for systematic reviews of randomized control trials in health care from the Potsdam Consultation on Meta-Analysis | Q40590970 | ||
| Methods for exploring heterogeneity in meta-analysis | Q40689559 | ||
| P275 | copyright license | Creative Commons Attribution 2.0 Generic | Q19125117 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | bias | Q742736 |
| heterogeneity | Q928498 | ||
| systematic review | Q1504425 | ||
| biomedical investigative technique | Q66648976 | ||
| statistical data interpretation | Q67369489 | ||
| P304 | page(s) | 111 | |
| P577 | publication date | 2012-07-30 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | BMC Medical Research Methodology | Q15752152 |
| P1476 | title | Investigating clinical heterogeneity in systematic reviews: a methodologic review of guidance in the literature | |
| P478 | volume | 12 |
| Q47154816 | A Systematic Review and Comprehensive Critical Analysis Examining the Use of Prednisolone for the Treatment of Mild to Moderate Croup |
| Q36368781 | A large-scale assessment of temporal trends in meta-analyses using systematic review reports from the Cochrane Library. |
| Q42318630 | An approach to addressing subpopulation considerations in systematic reviews: the experience of reviewers supporting the U.S. Preventive Services Task Force. |
| Q35925310 | Applicable or non-applicable: investigations of clinical heterogeneity in systematic reviews |
| Q93072365 | Benefits and Harms of Omalizumab Treatment in Adolescent and Adult Patients With Chronic Idiopathic (Spontaneous) Urticaria: A Meta-analysis of "Real-world" Evidence |
| Q38565137 | Choice architecture interventions for increased vegetable intake and behaviour change in a school setting: a systematic review |
| Q24187815 | Chronic disease management programmes for adults with asthma |
| Q34978106 | Consensus-based recommendations for investigating clinical heterogeneity in systematic reviews |
| Q58701088 | Effectiveness of targeting fathers for breastfeeding promotion: systematic review and meta-analysis |
| Q35647595 | Exploring treatment by covariate interactions using subgroup analysis and meta-regression in cochrane reviews: a review of recent practice |
| Q36123865 | Factors Influencing Removable Partial Denture Patient-Reported Outcomes of Quality of Life and Satisfaction: A Systematic Review. |
| Q21090694 | Idraparinux or idrabiotaparinux for long-term venous thromboembolism treatment: a systematic review and meta-analysis of randomized controlled trials |
| Q24188176 | Improving maternal, newborn and women's reproductive health in crisis settings |
| Q94398288 | Improving maternal, newborn and women's reproductive health in crisis settings |
| Q90615830 | Inguinal hernia repair in preterm neonates: is there evidence that spinal or general anaesthesia is the better option regarding intraoperative and postoperative complications? A systematic review and meta-analysis |
| Q98784958 | Modeling brain, symptom, and behavior in the winds of change |
| Q30235049 | Osteopathy for primary headache patients: a systematic review |
| Q52822060 | Patient education in rheumatoid arthritis: is the needs-based approach the way forward? |
| Q35077073 | Relevant baseline characteristics for describing patients with knee osteoarthritis: results from a Delphi survey |
| Q24289520 | STRengthening analytical thinking for observational studies: the STRATOS initiative |
| Q89583191 | Shift work and risk of skin cancer: A systematic review and meta-analysis |
| Q91963422 | Statistical Modeling and Aggregate-Weighted Scoring Systems in Prediction of Mortality and ICU Transfer: A Systematic Review |
| Q30648457 | Technology-based interventions for tobacco and other drug use in university and college students: a systematic review and meta-analysis |
| Q64228825 | The State of the Evidence for Whole-System, Multi-Modality Naturopathic Medicine: A Systematic Scoping Review |
| Q104568960 | The contribution of group prenatal care to maternal psychological health outcomes: A systematic review |
| Q30248214 | The paradox of sham therapy and placebo effect in osteopathy: A systematic review |
| Q60912968 | The prevalence of phantom limb pain and associated risk factors in people with amputations: a systematic review protocol |
| Q26996493 | The risk of elevated prolactin levels in pediatric patients exposed to antipsychotics for the treatment of schizophrenia and schizophrenia spectrum disorders: protocol for a systematic review and meta-analysis |
| Q33800372 | Transfer to hospital in planned home births: a systematic review |
| Q47152353 | Vitamin D supplementation during pregnancy: state of the evidence from a systematic review of randomised trials |
Search more.